Drug profile · INN
bepotastine besilate
TALION
bepotastine besilate (TALION) is a histamine h1 receptor antagonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — bepotastine besilate
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
bepotastine besilate (TALION) is a histamine h1 receptor antagonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is bepotastine besilate?
bepotastine besilate (TALION) is a histamine h1 receptor antagonist. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for bepotastine besilate?
TALION is a marketed brand name for bepotastine besilate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bepotastine besilate?
bepotastine besilate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.